Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Nuformix (NFX) Share News

IN BRIEF: Nuformix hires ex-Zeus Capital joint CEO Metcalfe as chair

25th Aug 2026 12:17

Nuformix PLC - London-based pharmaceutical development company focused on fibrosis and oncology via drug repurposing - Hires Tim Metcalfe to be non-executive chair, starting September 1, Tuesday next week. Metcalfe is a corporate financier who among other City roles was joint CEO of Zeus Capital Ltd. At Nuformix, he replaces Julian Gilbert, who is stepping down for "personal reasons". Gilbert has been on the board since 2020 and chair since 2022. Read More

Nuformix shares up after positive preclinical studies against fibrosis

19th Aug 2026 16:52

(Alliance News) - Nuformix PLC shares spiked on Wednesday after the company shared positive results from its first preclinical studies on inhaled treatments for fibrosis. Read More

LONDON MARKET MIDDAY: Shares fall as Middle East tensions weigh

19th Aug 2026 12:07

(Alliance News) - Stock prices in London were lower at midday on Wednesday, as investors digested UK and eurozone inflation data and monitored escalating tensions in the Middle East. Read More

WINNERS & LOSERS: Defence Holdings pares losses, explains investment

19th Aug 2026 11:07

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday. Read More

WINNERS & LOSERS: Made Tech surges on deal win; Time Out climbs

18th Aug 2026 10:41

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

WINNERS & LOSERS: Gran Tierra sells Latam arm; S4 Capital narrows loss

5th Aug 2026 11:20

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday. Read More

WINNERS & LOSERS: capAI gains exclusive licence for Ageotype platform

23rd Jul 2026 11:14

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More

WINNERS & LOSERS: Harvest Minerals surges on Brazil portfolio takeover

21st Jul 2026 11:20

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

WINNERS & LOSERS: DeFi Development soars; Fiinu loss widens

29th Jun 2026 11:17

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More

WINNERS & LOSERS: Sunda receives regulator notice, Record cuts payout

19th Jun 2026 10:35

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More

WINNERS & LOSERS: Smiths News, RC365 sign deals; PZ Cussons ups view

17th Jun 2026 10:28

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday. Read More

WINNERS & LOSERS: Reabold Resources eyes Union Jack; oil stocks fall

15th Jun 2026 11:26

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More

WINNERS & LOSERS: Virgin Wines cuts guidance; Cizzle rises on patent

12th Jun 2026 11:30

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More

WINNERS & LOSERS: Seraphim Space surges; Silver Bullet plans to delist

9th Jun 2026 11:06

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

WINNERS & LOSERS: GENinCode loss widens; Audioboom calls off bid talks

8th Jun 2026 11:37

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More

IN BRIEF: Nuformix interim loss narrows; aims to raise value of assets

28th May 2026 14:33

Nuformix PLC - London-based developer of treatments for fibrosis and oncology - Pretax loss narrows to GBP346,577 in the six months ended March 31, from GBP376,668 a year prior. Looking ahead, Nuformix says: "The company continues to advance and exploit the current assets within the portfolio through the research & development and business development activities as set out above. The strategy of the group is to continue to increase the value of its existing assets while maintaining tight control of costs, including conducting business development/licensing activities using a structured and data-driven approach, with the goal of seeking global licensing deals." Read More

WINNERS & LOSERS: S4 Capital hit by "client caution"; NAHL in profit

7th May 2026 09:55

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More

WINNERS & LOSERS: Ramsdens ups profit view; Reach revenue falls

6th May 2026 10:03

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday. Read More

WINNERS & LOSERS: James Cropper sees earnings up; Block sells stake

14th Apr 2026 11:37

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

WINNERS & LOSERS: BRCK rejects M&A approach; Peel Hunt to beat view

31st Mar 2026 10:55

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

FTSE 100 Latest
Value10,765.87
Change9.42